Application of potato peptide in preparation of product for relieving gout
The potato peptide preparation process, which combines salt solution extraction, compound amino acid treatment, and specific protease combination, solves the problems of poor extraction effect and uneven molecular weight distribution of potato peptides, and achieves the effect of effectively relieving gouty arthritis and regulating purine metabolism.
Patent Information
- Application Number
- CN202411065331.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing technologies for extracting potato peptides are ineffective, resulting in protein loss and waste. Furthermore, different enzymatic hydrolysis processes lead to significant differences in peptide molecular weight distribution, making it difficult to obtain potato peptides with the target molecular weight distribution. Consequently, these technologies cannot effectively alleviate gouty arthritis or regulate purine metabolism.
Potato protein was extracted using a salt solution, starch was separated by adding a complex amino acid mixture, and the enzyme was immobilized using a specific protease combination and a modified inorganic carrier to control the enzymatic hydrolysis process, thereby obtaining potato peptides with a specific molecular weight distribution.
The extraction rate of potato protein was improved, and the obtained potato peptides can effectively inhibit xanthine oxidase, regulate purine metabolism, relieve gouty arthritis, reduce uric acid levels, reduce peptide loss, and improve enzymatic hydrolysis and separation efficiency.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioactive peptides, and particularly relates to application of potato peptides in preparing a product for relieving gout. Background Art
[0002] Studies have shown that potatoes have high nutritional value and can provide the human body with sufficient minerals, VC, carbohydrates, and proteins. The essential amino acid balance of potato protein is better than other plant proteins, comparable to whole eggs and casein, and its protein net digestibility (PER) can reach 2.3. Experiments on maintaining human nitrogen balance have shown that potato protein is better than other crop proteins. Peptides are important substances involved in metabolism in the body, especially those functional peptides with special physiological activities have attracted much attention in recent years. Potatoes contain about 3% protein, which can provide the human body with a large amount of high-quality bioactive peptides to achieve medical and health care effects.
[0003] The peptides generated by protein hydrolysis are easier to absorb in the human body than free amino acids. Small peptides with a molecular weight of less than 6000Da have biological activities that food proteins and amino acids do not have, and have good health benefits. Pihlanto et al. used three proteases, Alcalase, Neutrase and Esperase, to hydrolyze potato protein and found that the hydrolyzate after ultrafiltration had an inhibitory effect on angiotensin converting enzyme. This angiotensin converting enzyme inhibitor (ACEI) is a small molecule active peptide that can scavenge superoxide anion free radicals, hydroxyl free radicals, etc., and can prevent and treat diseases such as atherosclerosis and diabetes. It can be seen that the research on the physiological activity of potato peptides in various aspects is of great significance.
[0004] However, there are no reports on the use of potato peptides in gout relief products. Gout is a recurrent inflammatory disease caused by increased purine biosynthesis metabolism, excessive uric acid production or poor uric acid excretion, resulting in increased uric acid in the blood, and deposition of urate crystals in the synovium, bursa, cartilage and other tissues of the joints. Therefore, gout is a disease that seriously affects joint health, and its pathogenesis is closely related to uric acid metabolism disorders. Patients may experience sudden pain and swelling, and even severe pain with the slightest touch. In addition to acute gouty arthritis, gout may also lead to chronic arthritis, and long-term uric acid deposition may form tophi around the joints, affecting joint function. Therefore, gout is not only a joint disease, but also a disease that has a serious impact on the overall health and quality of life of patients. Timely diagnosis and treatment are essential for relieving symptoms and preventing recurrence.
[0005] Most of the existing gout relieving drugs are chemically synthesized drugs, which are prone to side effects. Therefore, it is necessary to carry out research on potato peptides in relieving gout, especially in regulating purine metabolism in the human body and relieving gouty arthritis.
[0006] The preparation process of potato peptides generally includes extracting potato protein from potato raw materials, and then enzymatically hydrolyzing the potato protein to obtain potato peptides with smaller molecular weight. However, the extraction effect of potato protein in the existing process is not good, resulting in loss and waste of potato protein. In addition, potato peptides with different molecular weight distributions represent different biological activities. During the enzymatic hydrolysis of potato protein, the molecular weight distribution of peptides caused by different enzymes varies greatly. In order to obtain potato peptides with target molecular weight distribution, it is necessary to control the type of enzyme and the enzymatic hydrolysis effect to obtain potato peptides with better and stable molecular weight distribution.
[0007] In summary, how to provide a potato peptide for use in the preparation of a product for relieving gout is an urgent problem to be solved. Summary of the invention
[0008] The purpose of the present invention is to overcome the deficiencies of the prior art and provide an application of potato peptides in the preparation of a product for relieving gout, and to achieve the effect of regulating purine metabolism in the human body and relieving gouty arthritis by controlling the molecular weight distribution of the potato peptides. At the same time, the present invention also provides a preparation process of the potato peptides, firstly using a salt solution to extract protein from potatoes, then adding a composite amino acid treatment to promote the separation of starch, the combination of the two helps to improve the extraction effect of potato protein, and finally using a specific protease combination and a modified inorganic carrier immobilized enzyme technology to enzymatically hydrolyze the potato protein, so as to obtain the potato peptides with a specific molecular weight distribution of the present invention.
[0009] In order to achieve the above object, the technical solution adopted by the present invention is:
[0010] The present invention provides a potato peptide, the molecular weight distribution of which is:
[0011] The relative percentage of peptides with a relative molecular mass of 3000-5000 is 0.3-8.0%;
[0012] The relative percentage of peptides with a relative molecular mass of 2000-3000 is 0.5-10.0%;
[0013] The relative percentage of peptides with a relative molecular mass of 1000-2000 is 1.0-10.0%;
[0014] The relative percentage of peptides with a relative molecular mass of 500-1000 was 6.0-18.0%;
[0015] The relative percentage of peptides with molecular weights of 180-500 was 15.5-30%;
[0016] The relative percentage of peptides with a relative molecular mass of less than 180 was 50-70%.
[0017] Preferably, the peptide molecular weight distribution of potato peptides is:
[0018] The relative percentage of peptides with a relative molecular mass of 3000-5000 is 0.5-4.0%;
[0019] The relative percentage of peptides with a relative molecular mass of 2000-3000 was 1.0-6.0%;
[0020] The relative percentage of peptides with a relative molecular mass of 1000-2000 was 3.0-7.0%;
[0021] The relative percentage of peptides with a relative molecular mass of 500-1000 was 8.0-14.0%;
[0022] The relative percentage of peptides with molecular weights of 180–500 was 18–26%;
[0023] The relative percentage of peptides with a relative molecular mass of less than 180 was 55-68%.
[0024] The present invention also provides application of the potato peptide in preparing a product for alleviating gout.
[0025] The invention also provides a nutritional product comprising the potato peptide.
[0026] The present invention also provides a method for preparing the potato peptide, comprising the following steps:
[0027] (1) Extraction of potato protein: Wash and chop the potato raw material, extract it with a salt solution to obtain an extract, then pass it through a 100-160 mesh sieve, centrifuge the filtrate, and take the supernatant to obtain a potato protein solution;
[0028] (2) Concentration of potato protein: filtering the crude potato protein solution obtained in step (1) (at 30-45° C.) through an ultrafiltration membrane, and taking the retentate to obtain a protein concentrate;
[0029] (3) Enzymatic hydrolysis: Add water to the protein concentrate obtained in step (2) and stir evenly, adjust the pH to 6.5-7.0, then add protease, and perform enzymatic hydrolysis at 45-50° C. for 2-4 hours. After the enzymatic hydrolysis is completed, inactivate the enzyme (keep in a water bath at 80° C. for 5-10 minutes) to obtain an enzymatic hydrolyzate;
[0030] (4) Separation: The enzymatic hydrolysate obtained in step (3) is centrifuged to obtain a supernatant, the supernatant is filtered through a 5000Da ultrafiltration membrane, and the filtrate is freeze-dried to obtain potato peptides.
[0031] Preferably, before the extraction and sieving in step (1), the step further includes adding a composite amino acid to the extract, stirring for 10-30 minutes and then sieving, wherein the composite amino acid is at least two of glutamic acid, proline and threonine, and the amount of the composite amino acid added is 0.3-1% of the mass of the extract. More preferably, the composite amino acid includes glutamic acid, proline and threonine in a mass ratio of 1:(1-2):(1-3).
[0032] Preferably, in step (1), the amount of the salt solution added is 1-2 times the mass of the potato raw material, the salt is one or more of sodium chloride, sodium bisulfite and sodium citrate, and the concentration of the salt in the salt solution is 0.02-25mM. Specifically, the concentrations of sodium chloride, sodium bisulfite and sodium citrate in the salt solution are 0.02-0.03mM, 15-25mM and 8-12mM, respectively. The salt solution extraction time is 1-4h and the temperature is 20-30°C.
[0033] In step (2), the pore size of the ultrafiltration membrane is 20-40 nm, and the membrane flux is 12-18 L / (m 2 h), the filtration pressure is 1-2.5 bar.
[0034] Preferably, in step (3), the amount of water added is 10-30 times the mass of the protein concentrate, and the amount of protease added is 1-3% of the mass of the protein concentrate, wherein the protease comprises flavor protease (enzyme activity 100,000-300,000 U / g) and trypsin (enzyme activity 100,000-500,000 U / g) in a mass ratio of 1: (0.5-1).
[0035] Preferably, the protease is immobilized on a modified inorganic carrier before use, and the immobilization method is: uniformly mix the protease with (50-100 times the amount) water, then add the modified inorganic carrier, soak for 1-3 hours, and evaporate the water under reduced pressure.
[0036] The preparation method of the modified inorganic carrier comprises the following steps:
[0037] Mix the epoxy-containing silane coupling agent and ethanol aqueous solution evenly, then add the inorganic carrier and stir evenly, soak for 1-2 hours, then heat to 80-120°C, add alkali and glucuronamide, reflux for 4-10 hours under stirring conditions, filter and take the residue after the reaction is completed, rinse the residue with water and dry it to obtain the modified inorganic carrier.
[0038] Preferably, the mass ratio of the protease to the modified inorganic carrier is 1:(20-50).
[0039] The mass ratio of the epoxy-containing silane coupling agent, the ethanol aqueous solution, and the inorganic carrier is 1: (50-200): (20-30);
[0040] The epoxy-containing silane coupling agent is 3-glycidyloxypropyltrimethoxysilane, 3-glycidyloxypropyltriethoxysilane or 3-glycidylpropyl(dimethoxy)methylsilane, and the molar ratio of the epoxy-containing silane coupling agent to glucuronamide is 1:(1-1.2).
[0041] The alkali is sodium hydroxide, potassium hydroxide or choline, and the amount of the alkali added is 0.2-0.5% of the mass of the epoxy-containing silane coupling agent.
[0042] The inorganic carrier is activated carbon, diatomaceous earth or porous ceramic powder.
[0043] Technical effects of the present invention:
[0044] 1. The present invention mainly controls the enzymatic hydrolysis process and the separation process to obtain potato active peptides with a specific molecular weight distribution. The potato active peptides have a certain inhibitory effect on xanthine oxidase, can block the metabolic conversion of hypoxanthine to xanthine and xanthine to uric acid, and can achieve the effect of relieving gout by regulating the purine metabolism in the human body and preventing metabolic disorders. At the same time, the present invention can also be used to relieve the discomfort symptoms caused by acute gouty arthritis and can be used to prepare a product for dissolving urate crystals.
[0045] 2. The present invention uses a salt solution to extract protein from potatoes, and can improve the extraction rate of potato protein by increasing the solubility of potato protein.
[0046] Since potato starch has strong hydration ability and poor coagulation property, it is easy to adhere to protein, so that part of the protein is removed together with the starch residue during the centrifugation process and causes loss. Therefore, the present invention adds composite amino acid treatment after salt solution extraction, which can improve the coagulation property of potato starch, reduce the solubility of potato starch, prevent potato starch from adhering to protein and causing protein loss, and further improve the extraction effect of potato protein.
[0047] The composite amino acid of the present invention is preferably a combination of three amino acids: glutamic acid, proline and threonine, which not only has better effects in improving the retrogradation of potato starch, reducing starch solubility, etc., but also can reduce the interaction between the salt solution and the starch, promote the separation of starch, and reduce the residue of starch in the potato protein solution; and the composite amino acid also helps to disperse the potato protein.
[0048] 3. The present invention uses a combination of two specific proteases (flavor protease + trypsin) to enzymolyze potato protein, and combines the immobilization technology of proteases to obtain potato peptides with a specific molecular weight distribution of the present invention, thereby achieving the purpose of inhibiting xanthine oxidase, regulating purine metabolism in the human body, and alleviating gouty arthritis.
[0049] 4. The present invention uses an inorganic modified carrier to fix the protease, which can stabilize the protease and thus improve the enzymatic hydrolysis effect. After the inorganic carrier is treated with a silane coupling agent, its compatibility with the protease is enhanced, which is beneficial to the fixation of the protease and has better stability in the enzymatic hydrolysis solution.
[0050] 5. The modified inorganic carrier of the present invention is grafted with glucuronamide through an epoxy-containing silane coupling agent. The covalent bond structure formed by the grafting not only has better affinity with protease and better adsorption of protease, but also has affinity for potato protein, thereby improving the enzymatic hydrolysis effect. Finally, when the enzymatic hydrolysis is completed, part of the unhydrolyzed protein can be adsorbed, so that part of the unhydrolyzed protein is removed together with the immobilized protease in the centrifugation step, reducing the entrainment of hydrolyzed peptides during protein removal in the subsequent ultrafiltration membrane step, reducing the loss of hydrolyzed peptides, promoting the separation between unhydrolyzed protein and hydrolyzed peptides, and improving the separation effect.
[0051] In addition, during the hydrolysis of potato protein, as the degree of hydrolysis increases, the protein content decreases, and the length and molecular weight of the peptide chain decrease, and the viscosity of the hydrolyzate decreases, so that the immobilized protease is unstable in the hydrolyzate and easily deposited on the bottom. The modified inorganic carrier used by the immobilized protease of the present invention is grafted with glucosamide by an epoxy-containing silane coupling agent, and a branched chain that helps dispersion is introduced on the surface of the modified inorganic carrier, which can improve the dispersibility and stability of the immobilized protease in the hydrolyzate. DETAILED DESCRIPTION
[0052] The above scheme is further described below in conjunction with specific embodiments; it should be understood that these embodiments are used to illustrate the basic principles, main features and advantages of the present invention, and the present invention is not limited to the scope of the following embodiments; the implementation conditions adopted in the embodiments can be further adjusted according to specific requirements, and the implementation conditions not specified are usually the conditions in conventional experiments.
[0053] Unless otherwise specified in the following examples, all raw materials are commercially available or prepared by conventional methods in the art.
[0054] Example 1
[0055] This embodiment provides a method for preparing potato peptides, comprising the following steps:
[0056] (1) Extraction of potato protein: Wash and chop the potato raw material, extract it with 1.5 times the amount of 0.025 mM sodium chloride solution at 25°C for 2.5 h to obtain an extract, then pass it through a 120-mesh sieve, centrifuge the filtrate, and take the supernatant to obtain a potato protein solution;
[0057] (2) Concentration of potato protein: The crude potato protein solution obtained in step (1) (at 35° C.) was filtered through an ultrafiltration membrane with a pore size of 30 nm and a membrane flux of 15 L / (m 2 h), the filtration pressure is 1.8 bar, and the retentate is taken after filtration to obtain the protein concentrate;
[0058] (3) Enzymatic hydrolysis: add 20 times the amount of water to the protein concentrate obtained in step (2), stir evenly, adjust the pH to 6.8, then add protease, the amount of protease added is 2% of the mass of the protein concentrate, and perform enzymatic hydrolysis at 48°C for 3 hours. After the enzymatic hydrolysis is completed, inactivate the enzyme (keep the solution in a water bath at 80°C for 10 minutes) to obtain an enzymatic solution; the protease comprises flavor protease (enzyme activity 100,000-300,000 U / g) and trypsin (enzyme activity 100,000-500,000 U / g) in a mass ratio of 1:0.75.
[0059] (4) Separation: The enzymatic hydrolysate obtained in step (3) is centrifuged to obtain a supernatant, the supernatant is filtered through a 5000Da ultrafiltration membrane, and the filtrate is freeze-dried to obtain potato peptides.
[0060] Example 2
[0061] On the basis of Example 1, this example provides a method for preparing potato peptides, wherein step (1) further comprises adding composite amino acids (the amount added is 0.6% of the mass of the extract) to the extract before screening after extraction, and stirring for 20 minutes before screening, wherein the composite amino acids comprise glutamic acid, proline, and threonine in a mass ratio of 1:1.5:2.
[0062] Example 3
[0063] Based on Example 2, this example provides a method for preparing potato peptides. In the enzymatic hydrolysis method of step (3), the protease is immobilized on a modified inorganic carrier before use. The immobilization method is as follows: the protease is mixed evenly with (80 times the amount) of water, then the modified inorganic carrier is added, soaked for 2 hours, and the water is evaporated under reduced pressure. The mass ratio of the protease to the modified inorganic carrier is 1:30.
[0064] The preparation method of the modified inorganic carrier comprises the following steps:
[0065] The epoxy-containing silane coupling agent (3-glycidyloxypropyltrimethoxysilane) and ethanol aqueous solution are evenly mixed, and then an inorganic carrier (porous ceramic powder) is added and stirred evenly. The mixture is soaked for 1.5 hours, and then the temperature is raised to 100°C. Alkali (sodium hydroxide, the amount added is 0.35% of the mass of the epoxy-containing silane coupling agent) and glucuronamide are added, and the mixture is refluxed for 6 hours under stirring conditions. After the reaction is completed, the residue is filtered out, and the residue is rinsed with water and dried to obtain a modified inorganic carrier.
[0066] The mass ratio of the epoxy-containing silane coupling agent, the ethanol aqueous solution and the inorganic carrier is 1:100:25; the molar ratio of the epoxy-containing silane coupling agent to glucuronamide is 1:1.1.
[0067] Example 4
[0068] This embodiment provides a method for preparing potato peptides, comprising the following steps:
[0069] (1) Extraction of potato protein: Wash and chop potato raw materials, extract with 1 times the amount of 0.02 mM sodium chloride solution at 20° C. for 2 h to obtain an extract, add complex amino acids (the amount added is 0.3% of the mass of the extract) to the extract, stir for 10 min, then pass through a 100-mesh sieve, centrifuge the filtrate, and take the supernatant to obtain a potato protein solution; the complex amino acids include glutamic acid, proline, and threonine in a mass ratio of 1:1:1.
[0070] (2) Concentration of potato protein: The crude potato protein solution obtained in step (1) (at 30° C.) was filtered through an ultrafiltration membrane with a pore size of 20 nm and a membrane flux of 13 L / (m 2 h), the filtration pressure is 1.2 bar, and the retentate is taken after filtration to obtain the protein concentrate;
[0071] (3) Enzymatic hydrolysis: add 10 times the amount of water to the protein concentrate obtained in step (2), stir evenly, adjust the pH to 6.5, then add protease, the amount of protease added is 1% of the mass of the protein concentrate, and perform enzymatic hydrolysis at 45°C for 4 hours. After the enzymatic hydrolysis is completed, inactivate the enzyme (keep the water bath at 80°C for 10 minutes) to obtain an enzymatic solution; the protease includes flavor protease (enzyme activity 100,000-300,000 U / g) and trypsin (enzyme activity 100,000-500,000 U / g) in a mass ratio of 1:0.5.
[0072] (4) Separation: The enzymatic hydrolysate obtained in step (3) is centrifuged to obtain a supernatant, the supernatant is filtered through a 5000Da ultrafiltration membrane, and the filtrate is freeze-dried to obtain potato peptides.
[0073] In the enzymatic hydrolysis method of step (3), the protease is immobilized on a modified inorganic carrier before use. The immobilization method is: the protease is mixed evenly with (50 times the amount) of water, then added to the modified inorganic carrier, soaked for 1 hour, and the water is evaporated under reduced pressure. The mass ratio of the protease to the modified inorganic carrier is 1:20.
[0074] The preparation method of the modified inorganic carrier comprises the following steps:
[0075] The epoxy-containing silane coupling agent (3-glycidyloxypropyltriethoxysilane) and ethanol aqueous solution are evenly mixed, and then an inorganic carrier (activated carbon) is added and stirred evenly. The mixture is soaked for 1 hour, and then the temperature is raised to 80°C. Alkali (potassium hydroxide, the amount added is 0.2% of the mass of the epoxy-containing silane coupling agent) and glucuronamide are added, and the mixture is refluxed for 8 hours under stirring conditions. After the reaction is completed, the residue is filtered out, and the residue is rinsed with water and dried to obtain a modified inorganic carrier.
[0076] The mass ratio of the epoxy-containing silane coupling agent, the ethanol aqueous solution and the inorganic carrier is 1:50:20; the molar ratio of the epoxy-containing silane coupling agent to glucuronamide is 1:1.
[0077] Example 5
[0078] This embodiment provides a method for preparing potato peptides, comprising the following steps:
[0079] (1) Extraction of potato protein: Wash and chop potato raw materials, extract with 2 times the amount of 10 mM sodium citrate solution at 30°C for 4 h to obtain an extract, add complex amino acids (the amount added is 1% of the mass of the extract) to the extract, stir for 30 min, and then pass through a 160-mesh sieve. The filtrate is centrifuged and the supernatant is obtained to obtain a potato protein solution; the complex amino acids include glutamic acid, proline, and threonine in a mass ratio of 1:2:3.
[0080] (2) Concentration of potato protein: The crude potato protein solution obtained in step (1) (at 45° C.) was filtered through an ultrafiltration membrane with a pore size of 40 nm and a membrane flux of 18 L / (m 2 h), the filtration pressure is 2.5 bar, and the retentate is taken after filtration to obtain the protein concentrate.
[0081] (3) Enzymatic hydrolysis: add 30 times the amount of water to the protein concentrate obtained in step (2) and stir evenly, adjust the pH to 7.0, then add protease in an amount of 3% of the mass of the protein concentrate, perform enzymatic hydrolysis at 50° C. for 2 h, inactivate the enzyme after the enzymatic hydrolysis is completed (keep in a water bath at 80° C. for 5-10 min), and obtain an enzymatic solution; the protease comprises flavor protease (enzyme activity 100,000-300,000 U / g) and trypsin (enzyme activity 100,000-500,000 U / g) in a mass ratio of 1:1.
[0082] (4) Separation: The enzymatic hydrolysate obtained in step (3) is centrifuged to obtain a supernatant, the supernatant is filtered through a 5000Da ultrafiltration membrane, and the filtrate is freeze-dried to obtain potato peptides.
[0083] In the enzymatic hydrolysis method of step (3), the protease is immobilized on a modified inorganic carrier before use. The immobilization method is: the protease is mixed evenly with (100 times the amount) of water, then added to the modified inorganic carrier, soaked for 3 hours, and the water is evaporated under reduced pressure. The mass ratio of the protease to the modified inorganic carrier is 1:50.
[0084] The preparation method of the modified inorganic carrier comprises the following steps:
[0085] The epoxy-containing silane coupling agent (3-glycidylpropyl(dimethoxy)methylsilane) and ethanol aqueous solution are evenly mixed, and then an inorganic carrier (diatomaceous earth) is added and stirred evenly, and then the mixture is soaked for 2 hours, and then the temperature is raised to 110°C, and a base (choline, the amount added is 0.5% of the mass of the epoxy-containing silane coupling agent) and glucuronamide are added, and the mixture is refluxed for 4 hours under stirring conditions. After the reaction is completed, the residue is filtered out, and the residue is rinsed with water and dried to obtain a modified inorganic carrier.
[0086] The mass ratio of the epoxy-containing silane coupling agent, the ethanol aqueous solution and the inorganic carrier is 1:200:30; the molar ratio of the epoxy-containing silane coupling agent to glucuronamide is 1:1.2.
[0087] Example 6
[0088] This embodiment provides a method for preparing potato peptides, which is different from that of Embodiment 2 in that the composite amino acids include glutamic acid and proline in a mass ratio of 1:1.5.
[0089] Example 7
[0090] This embodiment provides a method for preparing potato peptides, which is different from that of Embodiment 2 in that the composite amino acids include glutamic acid and threonine in a mass ratio of 1:2.
[0091] Example 8
[0092] This embodiment provides a method for preparing potato peptides, which is different from that of Embodiment 2 in that the composite amino acids include proline and threonine in a mass ratio of 1.5:2.
[0093] Comparative Example 1
[0094] The difference between this comparative example and Example 2 is that in step (1), the composite amino acid is added during the extraction with the salt solution.
[0095] Comparative Example 2
[0096] The difference between this comparative example and Example 2 is that in step (1), the amount of the composite amino acid added is 0.1% of the mass of the extract.
[0097] Comparative Example 3
[0098] The difference between this comparative example and Example 2 is that in step (1), the amount of the composite amino acid added is 1.2% of the mass of the extract.
[0099] Comparative Example 4
[0100] The difference between this comparative example and Example 1 is that the protease only includes flavor protease (enzyme activity 100,000-300,000 U / g).
[0101] Comparative Example 5
[0102] The difference between this comparative example and Example 1 is that the protease only includes trypsin (enzyme activity 100,000-500,000 U / g).
[0103] Comparative Example 6
[0104] The difference between this comparative example and Example 1 is that the protease only includes neutral protease (AS.1398, enzyme activity 100,000-300,000 U / g).
[0105] Comparative Example 7
[0106] The difference between this comparative example and Example 3 is that in step (3), the mass ratio of the flavor protease to the trypsin is 1:0.3.
[0107] Comparative Example 8
[0108] The difference between this comparative example and Example 3 is that in step (3), the mass ratio of flavor protease to trypsin is 1:1.2.
[0109] Comparative Example 9
[0110] The difference between this comparative example and Example 3 is that in step (3), the inorganic carrier is not modified and the protease is directly immobilized.
[0111] Comparative Example 10
[0112] The difference between this comparative example and Example 3 is that in step (3), the preparation method of the modified inorganic carrier is: mix the epoxy-containing silane coupling agent (3-glycidyloxypropyltrimethoxysilane) and the ethanol aqueous solution evenly, then add the inorganic carrier (porous ceramic powder) and stir evenly, soak for 1.5 hours, then filter out the residue, rinse the residue with water and dry it to obtain the modified inorganic carrier.
[0113] Comparative Example 11
[0114] The difference between this comparative example and Example 3 is that in step (3), in the preparation method of the modified inorganic carrier, glucosamide is replaced by octylamine.
[0115] Comparative Example 12
[0116] The difference between this comparative example and Example 3 is that in step (3), in the preparation method of the modified inorganic carrier, glucosamide is replaced by hexamethylenediamine.
[0117] 1. Molecular Weight Distribution of Potato Peptides of the Present Invention
[0118] The moisture content of the potato peptides prepared in Examples 1-5 and Comparative Examples 4-6 of the present invention is below 7.0%, meeting the relevant provisions of GB31611-2023. The potato peptides were analyzed by HPLC using conventional peptide analysis methods to analyze the molecular weight distribution of the potato peptides. The results are shown in Table 1.
[0119] Table 1
[0120]
[0121] As shown in Table 1, the potato peptides prepared in Examples 1-5 of the present invention are all active peptides with a relative molecular mass of less than 5000. The molecular weight distributions of the potato peptides prepared by different methods in Examples 1-5 show obvious differences, indicating that the enzymatic hydrolysis process has a major impact on the molecular weight distribution of the potato peptides. The molecular weight distributions of the potato peptides in Examples 1-5 are all within the molecular weight distribution range of the peptides of the present invention (the relative percentage of peptides with a relative molecular mass of 3000-5000 is 0.3-8.0%; the relative percentage of peptides with a relative molecular mass of 2000-3000 is 0.5-10.0%; the relative percentage of peptides with a relative molecular mass of 1000-2000 is 1.0-10.0%; the relative percentage of peptides with a relative molecular mass of 500-1000 is 6.0-18.0%; the relative percentage of peptides with a relative molecular mass of 180-500 is 15.5-30%; the relative percentage of peptides with a relative molecular mass of <180 is 50-70%).
[0122] By comparing Example 1 and Comparative Examples 4-6, it can be seen that after changing the type of protease, the molecular weight distribution of the potato peptides in Comparative Examples 4-6 is significantly affected and exceeds the molecular weight distribution range of the present invention, indicating that the type of protease in the enzymatic hydrolysis process has a great influence on the molecular weight distribution of the potato peptides.
[0123] By comparing Examples 2 and 3, it can be seen that immobilizing the protease during the enzymatic hydrolysis process will also change the molecular weight distribution of potato peptides.
[0124] 2. Biological activity of the potato peptide of the present invention
[0125] 1. In vitro inhibitory activity experiment of potato peptide xanthine oxidase
[0126] (1) Drug to be tested: potato peptides prepared in Examples 1-5 and Comparative Examples 4-6.
[0127] (2) Experimental methods:
[0128] The potato peptides prepared in Examples 1-5 and Comparative Examples 4-6 were respectively prepared into a test sample solution with a concentration of 4 mg / mL using a PBS buffer solution with a pH of 7.5, and the in vitro XO (xanthine oxidase) inhibition rates of the eight potato peptides were determined. The larger the in vitro XO inhibition rate value, the better the inhibitory activity of the potato peptide.
[0129] Xanthine solution (1.5mmol / L) and xanthine oxidase solution (0.1U / mL) were prepared with PBS buffer solution of pH=7.5. 125μL of the sample solution to be tested, 150μL of PBS buffer and 100μL of xanthine oxidase solution were added to a 1.5mL centrifuge tube, incubated at 37°C for 15min, 125μL of xanthine solution was added, and the incubation continued for 20min. Finally, 100μL of hydrochloric acid (1mol / L) was added to terminate the reaction. Controls without the sample to be tested, without xanthine oxidase, without xanthine oxidase and the sample to be tested were set up respectively. The absorbance at 290nm was measured, and the in vitro XO inhibition rate was calculated based on the absorbance. The results are shown in Table 2.
[0130] The calculation formula of in vitro XO inhibition rate is as follows:
[0131] In vitro XO inhibition rate (%) = [(1-(A 1 -A 3 ) / (A 2 -A 4 )]×100%.
[0132] Among them, A 1 : The absorbance value of the activity detection system containing xanthine, xanthine oxidase and sample;
[0133] A 2 : The absorbance value of the activity measurement system containing xanthine and xanthine oxidase but no sample;
[0134] A 3 : The absorbance value of the activity detection system containing xanthine substrate and sample but not xanthine oxidase;
[0135] A 4 : The absorbance value of the activity detection system containing xanthine, but not containing xanthine oxidase and sample.
[0136] Table 2
[0137]
[0138]
[0139] From the results in Table 2, it can be seen that the potato peptides prepared in Examples 1-5 of the present invention all have good xanthine oxidase inhibitory activity, and their in vitro XO inhibition rates are all above 40.25%, among which the inhibition rates of Examples 3-5 are as high as 57.99-58.93%, showing high XO inhibitory activity and can be used to regulate purine metabolism in the human body.
[0140] On the basis of Example 2, Example 3 changed the enzymatic hydrolysis process after the protease was immobilized, thereby changing the molecular weight distribution of the potato peptides, and finally showing different XO inhibitory activities, indicating that the potato peptides of Examples 3-5 of the present invention have better XO inhibitory activities.
[0141] Compared with Example 1, after the types of proteases were changed in Comparative Examples 4-6, their in vitro XO inhibition rates were all reduced.
[0142] 2. Experiment on the effect of potato peptides on serum uric acid levels in rats
[0143] (1) Experimental animals: Select normal grade SD male rats weighing 200-250 g.
[0144] (2) Drugs to be tested: potato peptides prepared in Examples 1-5 and Comparative Examples 4-6; and commercially available positive drug allopurinol.
[0145] (3) Experimental methods:
[0146] The rats were randomly divided into 11 groups, namely a blank control group, a model group, a positive drug allopurinol group (15 mg / kg dose), and 8 potato peptide groups (Examples 3-5 were tested at a low dose of 2 g / kg, a medium dose of 4 g / kg, and a high dose of 6 g / kg, respectively, and Examples 1, 2 and Comparative Examples 4-6 were only tested at a medium dose of 4 g / kg), with 10 rats in each group.
[0147] The blank control group and the model group were gavaged with an equal volume of 0.5% CMC-Na solution, and the other groups of animals were gavaged with the corresponding drugs, with the dosage volume of 1ml / 100g, once a day, for 6 consecutive days. 30 minutes after the last administration, the model group and each drug group were modeled with hyperuricemia, first gavaged with a dose of 300mg / kg hypoxanthine, with a dosage volume of 1ml / 100g, and then subcutaneously injected with a dose of 300mg / kg potassium salt of oxonate, with a dosage volume of 0.5ml / 100g. The blank control group was operated in the same way and given an equal volume of 0.5% CMC-Na solution and an equal volume of normal saline. One hour after modeling, blood was collected from the orbital venous plexus of the rats, serum was separated, and serum uric acid value was determined using a uric acid determination kit. The results are shown in Table 3.
[0148] Table 3
[0149]
[0150]
[0151] As shown in Table 3, compared with the blank control group, the blood uric acid value of the model group was significantly increased. Compared with the model group, the potato peptide administration group had different degrees of reduction effect on the elevated serum uric acid value caused by oral administration of hypoxanthine and subcutaneous injection of potassium salt of oxonate, indicating that potato peptide has the effect of reducing blood uric acid. In particular, the uric acid-lowering effect of Examples 3-5 is better, and the uric acid-lowering effect of the high-dose group is even comparable to that of the positive drug allopurinol, indicating the excellent effect of the potato of the present application on reducing uric acid.
[0152] On the basis of Example 2, Example 3 changed the enzymatic hydrolysis process after immobilizing the protease, and the uric acid lowering effect was improved. Compared with Example 1, the potato peptides obtained by changing the type of protease in Comparative Examples 4-6 all had reduced uric acid lowering effects.
[0153] 3. Experiment on the ability of potato peptides of the present invention to relieve gouty arthritis
[0154] (1) Effects of potato peptides on xylene-induced ear swelling in mice
[0155] Experimental animals: Select ordinary grade Kunming mice, male, weighing 18-22g.
[0156] Drugs to be tested: potato peptides prepared in Examples 1-5 and Comparative Examples 4-6; and commercially available positive drug aspirin.
[0157] Experimental method: The mice were randomly divided into 11 groups, namely, a blank control group, a model group, a positive drug aspirin group (240 mg / kg dose), and 8 potato peptide groups (Examples 3-5 were tested at a low dose of 2 g / kg, a medium dose of 4 g / kg, and a high dose of 6 g / kg, respectively, and Examples 1, 2 and Comparative Examples 4-6 were only tested at a medium dose of 4 g / kg), with 10 rats in each group.
[0158] The animals in each drug group were gavaged with the corresponding drugs, once a day, for 3 consecutive days, with a dosage volume of 0.2ml / 10g. The blank control group and the model group were gavaged with the same volume of 0.5% CMC-Na solution. 1 hour after the last administration, 20μl of xylene was dripped on the inner and outer sides of the left auricle of the mice in the model group and each drug group to induce inflammation. The right ear was used as a control. After 30 minutes of inflammation, the mice were killed by dislocating the cervical vertebra, and the ear pieces were punched in the same part of the left and right ears with a 7mm diameter puncher, and weighed on an electronic balance. The difference in weight between the two ear pieces was the ear swelling degree, and the swelling inhibition rate was calculated. The results are shown in Table 4.
[0159] Swelling inhibition rate (%) = [(ear swelling degree of model group - ear swelling degree of drug group) / ear swelling degree of model group] × 100%.
[0160] Table 4
[0161]
[0162] As shown in Table 4, the potato peptides prepared in Examples 1-5 of the present invention all have different degrees of inhibitory effects on xylene-induced mouse ear swelling, especially Examples 3-5 have more prominent inhibitory effects, indicating that potato peptides have good anti-inflammatory effects.
[0163] On the basis of Example 2, Example 3 changed the enzymatic hydrolysis process after the protease was immobilized, and the inhibitory effect on xylene-induced mouse ear swelling was improved. Compared with Example 1, the inhibitory effects of potato peptides obtained by changing the type of protease in Comparative Examples 4-6 were all reduced.
[0164] (2) Effects of potato peptides on acetic acid-induced writhing reactions in mice
[0165] Experimental animals: Select ordinary grade Kunming mice, male, weighing 18-22g.
[0166] Drugs to be tested: potato peptides prepared in Examples 1-5 and Comparative Examples 4-6; and commercially available positive drug indomethacin.
[0167] Experimental method: The mice were randomly divided into 11 groups, namely, a blank control group, a model group, a positive drug indomethacin group (6 mg / kg dose), and 8 potato peptide groups (Examples 3-5 were tested at a low dose of 2 g / kg, a medium dose of 4 g / kg, and a high dose of 6 g / kg, respectively, and Examples 1, 2 and Comparative Examples 4-6 were only tested at a medium dose of 4 g / kg), with 12 rats in each group.
[0168] The animals in each drug group were gavaged with the corresponding drug, with a dosage of 0.2 ml / 10 g, once a day for 3 consecutive days. The blank control group and the model group were gavaged with an equal volume of 0.5% CMC-Na solution in the same way. One hour after the last administration, each mouse in the model group and each drug group was intraperitoneally injected with 0.7% glacial acetic acid solution 0.2 ml. The number of twists of each mouse within 20 minutes after the injection of glacial acetic acid was observed and recorded, and the analgesic rate was calculated. The results are shown in Table 5.
[0169] Analgesia rate (%) = [(number of writhings in the model group - number of writhings in the drug group) / number of writhings in the model group] × 100%.
[0170] Table 5
[0171]
[0172] As shown in Table 5, the potato peptides prepared in Examples 1-5 of the present invention all have different degrees of inhibitory effects on the pain response caused by intraperitoneal injection of glacial acetic acid in mice, especially Examples 3-5 have more prominent inhibitory effects, indicating that the potato peptides have good analgesic effects.
[0173] On the basis of Example 2, Example 3 changed the enzymatic hydrolysis process after immobilizing the protease, and the analgesic effect was improved. Compared with Example 1, the analgesic effects of the potato peptides obtained by changing the type of protease in Comparative Examples 4-6 were all reduced.
[0174] (3) Effects of potato peptides on acute foot swelling induced by sodium urate in rats
[0175] Experimental animals: Select ordinary grade SD male rats, weighing 200-250g.
[0176] Drugs to be tested: potato peptides prepared in Examples 1-5 and Comparative Examples 4-6; and commercially available positive drug indomethacin.
[0177] Experimental method: The mice were randomly divided into 11 groups, namely, a blank control group, a model group, a positive drug indomethacin group (5 mg / kg dose), and 8 potato peptide groups (Examples 3-5 were tested at a low dose of 2 g / kg, a medium dose of 4 g / kg, and a high dose of 6 g / kg, respectively, and Examples 1, 2 and Comparative Examples 4-6 were only tested at a medium dose of 4 g / kg), with 12 rats in each group.
[0178] The blank control group and the model group were gavaged with an equal volume of 0.5% CMC-Na solution, and the other groups of animals were gavaged with the corresponding drugs, and the dosage volume was 1ml / 100g. The drug was administered once a day for 5 consecutive days. On the 4th day of administration, a point was marked under the left hind ankle joint of the rat with a marker pen, and the diameter of the ankle joint of each rat was measured with a vernier caliper as the normal value. Modeling was performed 1 hour after administration on the 5th day. A 1ml syringe was inserted into the inner side of the tibial tendon from a 45° direction on the dorsal side of the left hind ankle joint of the rat, and 0.1ml of sodium urate solution with a concentration of 50mg / ml was injected into the ankle joint cavity for modeling. The diameter of the same part was measured according to the aforementioned method 1, 2, and 24h after modeling, and the diameter difference before and after modeling was taken as the foot swelling degree. The results are shown in Table 6.
[0179] Table 6
[0180]
[0181] As shown in Table 6, the potato peptides prepared in Examples 1-5 of the present invention all have different degrees of inhibitory effects on acute foot swelling induced by sodium urate in rats, especially Examples 3-5 have more prominent inhibitory effects, indicating that potato peptides have a good inhibitory effect on rat foot joint swelling.
[0182] On the basis of Example 2, Example 3 changed the enzymatic hydrolysis process after immobilizing the protease, and the effect of inhibiting rat foot joint swelling became better. Compared with Example 1, the potato peptides obtained by changing the type of protease in Comparative Examples 4-6 had reduced effects on inhibiting rat foot joint swelling.
[0183] Through the above test on the molecular weight distribution of potato peptides, combined with the above three efficacy experiments (experiment on the in vitro inhibitory activity of potato peptides on xanthine oxidase, experiment on the influence of potato peptides on rat serum uric acid level and experiment on the relief ability of potato peptides on gouty arthritis), it can be seen that the molecular weight distribution of the potato peptides of the present invention has a greater influence on the in vitro inhibitory activity of xanthine oxidase, uric acid reduction and relief ability of gouty arthritis of potato peptides, especially Examples 3-5 have better efficacy, and their peptide molecular weight distributions are all within the preferred range of the peptide molecular weight distribution of the present invention. Within (the relative percentage of peptides with a relative molecular mass of 3000-5000 is 0.5-4.0%; the relative percentage of peptides with a relative molecular mass of 2000-3000 is 1.0-6.0%; the relative percentage of peptides with a relative molecular mass of 1000-2000 is 3.0-7.0%; the relative percentage of peptides with a relative molecular mass of 500-1000 is 8.0-14.0%; the relative percentage of peptides with a relative molecular mass of 180-500 is 18-26%; the relative percentage of peptides with a relative molecular mass <180 is 55-68%.).
[0184] III. Acute toxicity test of potato peptide of the present invention
[0185] Experimental animals: healthy Kunming mice, half male and half female, weighing 20-23g.
[0186] Drug to be tested: potato peptides prepared in Examples 1-5.
[0187] 1. Preliminary test
[0188] After 3 days of adaptive feeding, the mice were randomly divided into a blank control group and a drug administration group (administered with potato peptides prepared in Examples 1-5), 8 mice in each group, and were intragastrically administered after fasting for 3 days, with the administration volume of 0.4 ml / 10 g, and the administration doses were 6.0 g / kg, 7.5 g / kg, 10.0 g / kg, and 12.5 g / kg, respectively. The lethal dose range was determined through a preliminary test, and the blank control group was given an equal volume of distilled water.
[0189] The preliminary test results showed that no mice died in each group, and it was preliminarily determined that the potato peptide obtained by the present invention had extremely low toxicity, and it was impossible to obtain an LD 50 .
[0190] 2. Formal test
[0191] Healthy mice were randomly divided into a blank control group and a drug administration group (administered with the potato peptide prepared in Example 3), 10 mice in each group, and the drugs were administered by gavage after fasting for 3 days, with the administration volume of 0.4 ml / 10 g, and the administration doses were 10 g / kg, 14 g / kg, 18 g / kg, 24 g / kg, 28 g / kg, and 32 g / kg, respectively. The number of deaths of mice in each group was observed and recorded, and the clinical symptoms after administration were recorded, and the symptoms of the dead mice were recorded in time for autopsy.
[0192] The results of the formal test showed that no mice died or had other symptoms of poisoning in each group, and their appearance, diet and other activities were normal. After the test, the mice in the high-dose 24g / kg, 28g / kg and 32g / kg groups were dissected and their hearts, livers, spleens, lungs, kidneys and other organs were observed with the naked eye, and no abnormalities were found. This shows that the potato peptide obtained by the present invention is basically safe and non-toxic.
[0193] 4. Effect of potato protein extraction in the process for preparing potato peptides of the present invention
[0194] 1. Extraction rate of potato protein
[0195] The protein content of the potato protein solution obtained in Examples 1-3, 6-8 and step (1) of Comparative Example 1-3 of the present invention was determined according to GB 5009.5-2016 “National Food Safety Standard Determination of Protein in Food”, and then the extraction rate of potato protein was calculated. The results are shown in Table 7.
[0196] 2. Residual starch in potato protein solution
[0197] The potato protein solution extracted from the potato raw material may contain some starch residue (especially soluble starch). The residual starch content in the potato protein solutions obtained in Examples 1-3, 6-8 and step (1) of Comparative Example 1-3 of the present invention was measured according to GB / T 16287. The results are shown in Table 7.
[0198] Table 7
[0199] Group Extraction rate of potato protein (%) Starch content in potato protein solution (%) Example 1 72.8 2.24 Example 2 90.1 0.38 Example 3 90.6 0.41 Example 6 81.5 1.95 Example 7 83.3 1.98 Example 8 80.4 2.02 Comparative Example 1 77.8 1.84 Comparative Example 2 86.5 0.74 Comparative Example 3 85.7 0.69
[0200] As shown in Table 7, the extraction of potato protein from potato raw materials according to the methods of Examples 1-3 and 6-8 of the present invention has a good extraction effect, with the extraction rate being above 72.8% and the residual starch content being below 2.24%. After adding the composite amino acid to Examples 2, 3, and 6-8, the extraction rate of potato protein is significantly increased to above 80.4%, especially the extraction rates of Examples 2 and 3 are 90.1% and 90.6% respectively, indicating that the addition of the composite amino acid of the present invention is beneficial to improving the extraction rate of potato protein.
[0201] The composite amino acids composed of three amino acids in Examples 6-8 were replaced with a combination of two of the amino acids. Although the extraction rate was improved compared with Example 1, the improvement effect was not as good as that of the composite amino acids composed of three amino acids in Example 2. Compared with Example 2, Comparative Example 1 changed the order of adding the composite amino acids, that is, adding them during the extraction, and the extraction rate was significantly reduced. Comparative Examples 2 and 3 changed the amount of composite amino acids added, and the extraction rate was also reduced.
[0202] Comparing the starch content in the potato protein solution of Examples 1 and 2, it can be seen that the addition of the composite amino acid of the present invention not only improves the protein extraction rate, but also reduces the starch residue. After the combination of composite amino acids was changed in Examples 6-8, the starch residue became higher, slightly lower than that in Example 1, indicating that the effect of the composite amino acid type in Examples 6-8 is not as good as that in Example 2. Comparative Example 1 changed the order of adding composite amino acids, and Comparative Examples 2 and 3 changed the amount of composite amino acids added, and as a result, the starch residues in Comparative Examples 1-3 also became higher.
[0203] V. Enzymatic hydrolysis effect of potato protein in the process for preparing potato peptides of the present invention
[0204] The potato protein hydrolysate obtained in step (3) of Examples 1-5 and Comparative Examples 4-12 was taken, and the degree of hydrolysis was determined according to the document "Process Optimization of Preparation of Peptides by Enzymatic Hydrolysis of Potato Protein_Cao Yanping", and the recovery rate of the potato peptides separated in step (4) was calculated. The results are shown in Table 8.
[0205] Table 8
[0206] Group Potato protein hydrolysis degree (%) Recovery rate of potato peptides (%) Example 1 22.3 85.67 Example 2 22.8 86.28 Example 3 32.7 96.25 Example 4 32.4 95.74 Example 5 32.0 95.87 Comparative Example 4 17.0 — Comparative Example 5 15.6 — Comparative Example 6 18.8 — Comparative Example 7 29.1 — Comparative Example 8 29.8 — Comparative Example 9 25.7 88.74 Comparative Example 10 27.6 90.46 Comparative Example 11 28.3 91.57 Comparative Example 12 28.9 90.98
[0207] As shown in Table 8, the hydrolysis degree of potato protein obtained by the methods of Examples 1-5 of the present invention is all above 22.3%, and the recovery rate of potato peptides is all above 85.67%, and the hydrolysis effect and peptide recovery effect are good. In particular, the hydrolysis degree of Examples 3-5 is between 32.0-32.7%, and the recovery rate of potato peptides is between 95.74-96.25%, and the enzymatic hydrolysis effect and peptide recovery effect are relatively good.
[0208] On the basis of Example 2, in Examples 3-5, the protease was immobilized on a modified inorganic carrier during the enzymatic hydrolysis process. As a result, the hydrolysis degree of potato protein was significantly improved, indicating that the immobilization of the protease is conducive to the enzymatic hydrolysis of potato protein.
[0209] Compared with Example 1, Comparative Examples 4-6 changed the type of protease, and the hydrolysis degree of potato protein was significantly reduced. Compared with Example 3, Comparative Examples 7 and 8 changed the mass ratio of flavor protease and trypsin, and the hydrolysis degree of potato protein was also reduced. Comparative Examples 9-12 changed the preparation of the modified inorganic carrier, and as a result, the hydrolysis degree of potato protein was reduced, and the peptide recovery rate was also reduced, indicating that the use of the modified inorganic carrier of the present invention to immobilize the protease can simultaneously improve the protein hydrolysis rate and the peptide recovery rate.
[0210] VI. Dispersibility of the Immobilized Protease of the Present Invention
[0211] Potato peptides were prepared according to the methods of Examples 3, 9-12 of the present invention, and the dispersibility of the protease in the enzymatic solution after being immobilized on the modified inorganic carrier was observed. The results are shown in Table 9.
[0212] Table 9
[0213] Group Dispersibility of immobilized protease in enzymatic solution Example 3 Uniform dispersion, no sedimentation at the bottom Comparative Example 9 Most of them are deposited at the bottom of the enzymatic solution. Comparative Example 10 A small amount of it is deposited at the bottom of the enzymatic solution. Comparative Example 11 A small amount of it is deposited at the bottom of the enzymatic solution. Comparative Example 12 A small amount of it is deposited at the bottom of the enzymatic solution.
[0214] As shown in Table 9, during the preparation of potato peptides in Example 3 of the present invention, the dispersibility of the immobilized protease in the enzymatic solution was good. Compared with Example 3, Comparative Examples 9-12 changed the preparation of the modified inorganic carrier and the immobilization effect of the protease, resulting in poor dispersibility of the immobilized protease in the enzymatic solution.
Claims
1. Application of potato peptide in the preparation of a product for relieving gout.
2. The use according to claim 1, Features: The peptide molecular weight distribution of the potato peptide is: The relative percentage of peptides with a relative molecular mass of 3000-5000 was 0.3-8.0%; The relative percentage of peptides with a relative molecular mass of 2000-3000 is 0.5-10.0%; The relative percentage of peptides with a relative molecular mass of 1000-2000 was 1.0-10.0%; The relative percentage of peptides with a relative molecular mass of 500-1000 was 6.0-18.0%; The relative percentage of peptides with molecular weights of 180–500 was 15.5–30%; The relative percentage of peptides with a relative molecular mass of less than 180 was 50-70%.
3. A method for preparing the potato peptide according to claim 2, Features: The following steps are involved: (1) Extraction of potato protein: Wash and chop the potato raw material, extract it with a salt solution to obtain an extract, then pass it through a 100-160 mesh sieve, centrifuge the filtrate, and take the supernatant to obtain a potato protein solution; (2) Concentration of potato protein: filtering the crude potato protein solution obtained in step (1) through an ultrafiltration membrane, and taking the retentate to obtain a protein concentrate; (3) Enzymatic hydrolysis: add water to the protein concentrate obtained in step (2) and stir evenly, adjust the pH to 6.5-7.0, then add protease and perform enzymatic hydrolysis at 45-50°C for 2-4 hours. After the enzymatic hydrolysis is completed, inactivate the enzyme to obtain an enzymatic hydrolyzate; (4) Separation: The enzymatic hydrolysate obtained in step (3) is centrifuged to obtain a supernatant, the supernatant is filtered through a 5000Da ultrafiltration membrane, and the filtrate is freeze-dried to obtain potato peptides.
4. The method according to claim 3, Features: Before the step (1) is finished extracting and sieving, it also includes adding a composite amino acid to the extract, stirring for 10-30 minutes and then sieving, wherein the composite amino acid is at least two of glutamic acid, proline and threonine, and the amount of the composite amino acid added is 0.3-1% of the mass of the extract.
5. The method according to claim 3, Features: In step (1), the amount of the salt solution added is 1-2 times the mass of the potato raw material, the salt is one or more of sodium chloride, sodium bisulfite and sodium citrate, the concentration of the salt in the salt solution is 0.02-25 mM, the salt solution extraction time is 1-4h, and the temperature is 20-30°C; In step (2), the pore size of the ultrafiltration membrane is 20-40 nm, and the membrane flux is 12-18 L / (m 2 •h), the filtration pressure is 1-2.5 bar.
6. The method according to claim 3, Features: In step (3), the amount of water added is 10-30 times the mass of the protein concentrate, and the amount of protease added is 1-3% of the mass of the protein concentrate. The protease includes flavor protease and trypsin in a mass ratio of 1: (0.5-1).
7. The method according to claim 4, Features: The composite amino acids include glutamic acid, proline and threonine in a mass ratio of 1:(1-2):(1-3).
8. The method according to claim 3 or 6, Features: The protease is immobilized on a modified inorganic carrier and then used. The immobilization method is: the protease is mixed with water evenly, and then added to the modified inorganic carrier, soaked for 1-3 hours, and the water is evaporated under reduced pressure; The preparation method of the modified inorganic carrier comprises the following steps: Mix the epoxy-containing silane coupling agent and ethanol aqueous solution evenly, then add the inorganic carrier and stir evenly, soak for 1-2 hours, then heat to 80-120°C, add alkali and glucuronamide, reflux for 4-10 hours under stirring conditions, filter and take the residue after the reaction is completed, rinse the residue with water and dry it to obtain the modified inorganic carrier.
9. The method according to claim 8, Features: The mass ratio of the protease to the modified inorganic carrier is 1:(20-50); The mass ratio of the epoxy-containing silane coupling agent, the ethanol aqueous solution, and the inorganic carrier is 1: (50-200): (20-30); The epoxy-containing silane coupling agent is 3-glycidyloxypropyltrimethoxysilane, 3-glycidyloxypropyltriethoxysilane or 3-glycidylpropyl(dimethoxy)methylsilane, and the molar ratio of the epoxy-containing silane coupling agent to glucuronamide is 1:(1-1.2); The base is sodium hydroxide, potassium hydroxide or choline, and the amount of the base added is 0.2-0.5% of the mass of the epoxy-containing silane coupling agent; The inorganic carrier is activated carbon, diatomaceous earth or porous ceramic powder.
10. A nutritional product, Features: The invention comprises the potato peptide according to claim 2.
Citation Information
Cited By
Wheat gluten protein peptide with XOD inhibitory activity and application thereof
CN121159623A
